tivantinib
Showing 1 - 18 of 18
Advanced Solid Tumors Trial (Tivantinib, Anti-Cancer Combination Therapy)
Completed
- Advanced Solid Tumors
- Tivantinib
- Anti-Cancer Combination Therapy
- (no location specified)
Feb 17, 2021
Malignant Pleural Mesothelioma, Nonsquamous Nonsmall Cell Tumor of Lung Trial in Rozzano (Tivantinib)
Completed
- Malignant Pleural Mesothelioma
- Nonsquamous Nonsmall Cell Neoplasm of Lung
- Tivantinib
-
Rozzano, Milan, ItalyIstituto Clinico Humanitas
Jan 20, 2021
Hepatocellular Carcinoma Trial in Worldwide (Tivantinib, Placebo)
Completed
- Hepatocellular Carcinoma
- Tivantinib
- Placebo
-
Tucson, Arizona
- +112 more
Mar 12, 2021
Refractory Multiple Myeloma Trial in Houston (drug, other, procedure)
Completed
- Refractory Multiple Myeloma
- Tivantinib
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Aug 9, 2019
Metastatic Colorectal Cancer Trial in Worldwide (Tivantinib, Placebo, Cetuximab)
Completed
- Metastatic Colorectal Cancer
- Tivantinib
- +3 more
-
Beverly Hills, California
- +39 more
Mar 12, 2021
Non Squamous, Non-small-cell Lung Cancer Trial in Worldwide (Tivantinib, Placebo, Erlotinib)
Terminated
- Non Squamous, Non-small-cell Lung Cancer
- Tivantinib
- +2 more
-
Tucson, Arizona
- +304 more
Mar 12, 2021
Hepatic Impairment, Solid Tumor, Cancer Trial in Los Angeles, Hackensack (Tivantinib)
Completed
- Hepatic Impairment
- +2 more
- Tivantinib
-
Los Angeles, California
- +1 more
Feb 8, 2019
Solid Tumors Trial in San Antonio (Tivantinib, Placebo)
Completed
- Solid Tumors
- Tivantinib
- Placebo
-
San Antonio, TexasSTART - South Texas Accelerated Research Therapeutics, LLC
Feb 8, 2019
Solid Tumors Trial in San Antonio (tivantinib, omeprazole, s-warfarin)
Completed
- Solid Tumors
- tivantinib
- +6 more
-
San Antonio, TexasSTART - South Texas Accelerated Research Therapeutics, LLC
Feb 8, 2019
Hormone-Resistant Prostate Cancer, Prostate Adenocarcinoma, Recurrent Prostate Carcinoma Trial in United States (Laboratory
Completed
- Hormone-Resistant Prostate Cancer
- +3 more
- Laboratory Biomarker Analysis
- +2 more
-
Washington, District of Columbia
- +19 more
Aug 13, 2018
Adult Solid Tumor Trial in United States (other, biological, drug)
Completed
- Adult Solid Neoplasm
- Laboratory Biomarker Analysis
- +4 more
-
Duarte, California
- +6 more
Apr 2, 2018
Recurrent Renal Cell Carcinoma, Stage III Renal Cell Cancer, Stage IV Renal Cell Cancer Trial in United States (Erlotinib
Completed
- Recurrent Renal Cell Carcinoma
- +4 more
- Erlotinib Hydrochloride
- +2 more
-
Tucson, Arizona
- +213 more
Dec 12, 2018
Solid Tumor Trial in Hershey, Pittsburgh (biological, other, drug)
Completed
- Solid Neoplasm
- Bevacizumab
- +3 more
-
Hershey, Pennsylvania
- +1 more
Oct 11, 2017
Malignant Solid Tumour, Gastroesophageal Cancer Trial in United States (Tivantinib, FOLFOX)
Completed
- Malignant Solid Tumour
- Gastroesophageal Cancer
- Tivantinib
- FOLFOX
-
New Haven, Connecticut
- +8 more
Oct 3, 2016
Epithelioid Mesothelioma, Recurrent Malignant Mesothelioma, Sarcomatoid Mesothelioma Trial in United States (Laboratory
Terminated
- Epithelioid Mesothelioma
- +5 more
- Laboratory Biomarker Analysis
- Tivantinib
-
Duarte, California
- +17 more
Aug 26, 2016
Estrogen Receptor Negative, HER2/Neu Negative, Progesterone Receptor Negative Trial in Boston (Laboratory Biomarker Analysis,
Completed
- Estrogen Receptor Negative
- +5 more
- Laboratory Biomarker Analysis
- Tivantinib
-
Boston, Massachusetts
- +1 more
Feb 23, 2016
Adult Solid Tumor Trial in Madison, Milwaukee (Laboratory Biomarker Analysis, Pharmacological Study, Temsirolimus)
Completed
- Adult Solid Neoplasm
- Laboratory Biomarker Analysis
- +3 more
-
Madison, Wisconsin
- +1 more
Oct 19, 2015
Childhood Solid Tumor Trial in Canada, United States (Laboratory Biomarker Analysis, Pharmacological Study, Tivantinib)
Completed
- Childhood Solid Neoplasm
- Laboratory Biomarker Analysis
- +2 more
-
Birmingham, Alabama
- +19 more
Jun 30, 2015